BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6349473)

  • 21. Carcinogenicity and mutagenicity testing of three isomeric N-nitroso-N-methylaminopyridines in rats.
    Preussmann R; Habs M; Pool BL
    J Natl Cancer Inst; 1979 Jan; 62(1):153-6. PubMed ID: 364151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons between carcinogenic potency and mutagenic potency to Salmonella in a series of derivatives of 4-dimethylaminoazobenzene (DAB).
    Ashby J; Lefevre PA; Styles JA; Charlesworth J; Paton D
    Mutat Res; 1982 Mar; 93(1):67-81. PubMed ID: 6801508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reevaluation of the mutagenicity and carcinogenicity of chemicals previously identified as "false positives" in the Salmonella typhimurium mutagenicity assay.
    Prival MJ; Dunkel VC
    Environ Mol Mutagen; 1989; 13(1):1-24. PubMed ID: 2642804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting rodent carcinogenicity from mutagenic potency measured in the Ames Salmonella assay.
    Fetterman BA; Kim BS; Margolin BH; Schildcrout JS; Smith MG; Wagner SM; Zeiger E
    Environ Mol Mutagen; 1997; 29(3):312-22. PubMed ID: 9142175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of a streamlined bacterial mutagenicity assay, the MINISCREEN.
    Brooks TM
    Mutagenesis; 1995 Sep; 10(5):447-8. PubMed ID: 8544759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of 133 compounds in the lambda prophage induction endpoint of the Microscreen assay and a comparison with S. typhimurium mutagenicity and rodent carcinogenicity assays.
    Rossman TG; Molina M; Meyer L; Boone P; Klein CB; Wang Z; Li F; Lin WC; Kinney PL
    Mutat Res; 1991 Aug; 260(4):349-67. PubMed ID: 1831244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative relationship between mutagenic potency in the Ara test of Salmonella typhimurium and carcinogenic potency in rodents. A study of 11 direct-acting monofunctional alkylating agents.
    Roldán-Arjona T; Luque-Romero FL; Ruiz-Rubio M; Pueyo C
    Carcinogenesis; 1990 Jun; 11(6):975-80. PubMed ID: 2189599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contamination is a frequent confounding factor in toxicology studies with anthraquinone and related compounds.
    Butterworth BE; Mathre OB; Ballinger KE; Adalsteinsson O
    Int J Toxicol; 2004; 23(5):335-44. PubMed ID: 15513832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of modified bacterial mutagenicity assays for the genotoxicity testing of mineral oils.
    Brooks TM; Priston RA; Wright AS; Watson WP
    Mutagenesis; 1995 Sep; 10(5):409-15. PubMed ID: 8544754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of 6 short-term tests for detecting organic chemical carcinogens.
    Purchase IF; Longstaff E; Ashby J; Styles JA; Anderson D; Lefevre PA; Westwood FR
    Br J Cancer; 1978 Jun; 37(6):873-903. PubMed ID: 354672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial-mammalian mutagenesis correlations: mechanistic significance for carcinogenesis.
    Bartsch H
    Ann N Y Acad Sci; 1983; 407():351-61. PubMed ID: 6576679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of urine and faeces after treatment of rats with known genotoxins.
    Willems MI; de Raat WK
    Carcinogenesis; 1985 Jul; 6(7):967-76. PubMed ID: 3893784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term tests in screening programs of environmental chemical carcinogens.
    Amlacher E
    Exp Pathol; 1982; 22(4):187-202. PubMed ID: 6761141
    [No Abstract]   [Full Text] [Related]  

  • 40. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
    Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
    Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.